PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-06-03

Date Title Company
03-Jun-2024 Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors Newswire
03-Jun-2024 Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors AccessWire
03-Jun-2024 ENCOURAGING NEW DATA PRESENTED ON KITE’S YESCARTA (AXICABTAGENE CILOLECUEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA Kite, a Gilead Company
03-Jun-2024 Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia H. Lundbeck A/S
03-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
03-Jun-2024 TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team TMC Pharma Services Ltd
03-Jun-2024 Qlucore starts project after receiving prestigious EU grant to advance personalized cancer treatment Qlucore
03-Jun-2024 STORM Therapeutics Presented Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 STORM Therapeutics
03-Jun-2024 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine HUTCHMED
03-Jun-2024 Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer Transgene
03-Jun-2024 Leading Biopharmaceutical Companies Unite to Advance SCE with Domino Domino Data Lab
03-Jun-2024 KindlyMD Announces Closing of $6.8 Million Initial Public Offering AccessWire
03-Jun-2024 PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation Newswire
03-Jun-2024 PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation AccessWire
03-Jun-2024 MedTech Outlook 2024 for Latin America Released AccessWire
03-Jun-2024 Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology AccessWire
03-Jun-2024 TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) AccessWire
03-Jun-2024 Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024 AccessWire
03-Jun-2024 CNS Pharmaceuticals Announces Reverse Stock Split AccessWire
03-Jun-2024 Aptevo Participating in the BIO International Convention AccessWire